Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Glandular and Epithelial

Explore clinical trials studying Neoplasms, Glandular and Epithelial. Study availability and eligibility vary by location and protocol.

12,664 public trials 2,917 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Glandular and Epithelial trial results

Recruiting

A Study of a Vaccine in Combination With Beta-glucan in People With Neuroblastoma

NCT06057948

Conditions
High-risk Neuroblastoma, Metastatic Neuroblastoma, Neoplasms, +9 more
Locations
  • Memorial Sloan Kettering at Basking Ridge (Consent only) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Consent Only) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Consent Only) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk-Commack (Consent only) Commack, New York, United States
View Trial Details
Recruiting

Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies

NCT01109394

Conditions
Endocrine Tumors, Eye Diseases, Eye Diseases, Hereditary, +27 more
Locations
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Children's Hospital of Orange County (CHOC Children's) Orange, Florida, United States
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
  • Tisch Cancer Institute, Mount Sinai Medical Center New York, United States
View Trial Details
Recruiting

Study of Futibatinib in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusion or Rearrangement

NCT05727176

Conditions
Adenocarcinoma, Advanced Cholangiocarcinoma, Carcinoma, +6 more
Locations
  • University of California San Diego UCSD - Moores Cancer Center La Jolla, California, United States
  • Tampa General Hospital Cancer Institute Tampa, Florida, United States
  • Henry Ford Health System Detroit, Michigan, United States
  • Gabrail Cancer Center Research Canton, Ohio, United States
View all 65 locations
View Trial Details
Recruiting

Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer

NCT06900595

Conditions
Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +16 more
Locations
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • Valley Children's Hospital Madera, California, United States
  • UCHealth University of Colorado Hospital Aurora, Colorado, United States
  • Lurie Children's Hospital-Chicago Chicago, Illinois, United States
View all 77 locations
View Trial Details
Recruiting

A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer

NCT06524544

Conditions
Carcinoma, Carcinoma, Transitional Cell, Locally Advanced Urothelial Carcinoma, +5 more
Locations
  • Cancer Center at Saint Joseph's Phoenix, Arizona, United States
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
  • UF Health Cancer Institute - Gainesville Gainesville, Florida, United States
View all 159 locations
View Trial Details
Recruiting

Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway Alteration

NCT04040205

Conditions
Chondrosarcoma, Eye Diseases, Eye Diseases, Hereditary, +18 more
Locations
  • Mayo Clinic Jacksonville, Florida, United States
  • University of Iowa Hospitals and Clinics Iowa City, Iowa, United States
  • Washington University in St. Louis St Louis, Missouri, United States
  • Froedtert Hospital & the Medical College of Wisconsin Milwaukee, Wisconsin, United States
View Trial Details

Related conditions